1. Home
  2. COVID Rapid Tests
  3. CareStart COVID-19 Rapid Antigen Tests (Box of 20)
CareStart COVID-19 Rapid Antigen Tests (Box of 20)
COVID-19 Rapid Antigen Tests

CareStart COVID-19 Rapid Antigen Tests (Box of 20)

Your Price: $369.00
Part Number: RCHM-02071
Availability: In Stock and Ships Same or Next Day!

Required

*
Quantity Price
5 - 9 $349.00
10 - 20 $344.00
21 - 49 $329.00
50+ $304.00

Access Bio's CARESTART COVID-19 Antigen Rapid Test


UPDATED 2/1/21: FDA has authorized ANTERIOR NASAL SWAB collection. (Shallow nostril swab. See updated IFU at bottom)

UPDATED 3/15/21: FDA authorized a 9-month shelf life for this product. VIEW THE NOTICE HERE



Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening, and detection of both clinical and asymptomatic COVID-19 cases is critical.

As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.

  • Lateral flow assay
  • Rapid results in 10 minutes
  • Nasopharyngeal swab specimen collection
  • Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver*, Certificate of Compliance, or Certificate of Accreditation
  • Detect SARS-CoV-2 nucleocapsid protein antigen
  • Identify acute infection in symptomatic patients with 88.4% sensitivity and 100% specificity
  • Designated as a CLIA waived test


Informational Brochure


 RAPID POC TEST

The continuing spread of COVID-19 has raised the importance of rapid screening.  Demand for rapid test kits is rising because unlike polymerase chain reaction (PCR) tests, they require no special equipment.  Access Bio, Inc., the world's leading manufacturer of rapid test kits for malaria, developed CareStart™ COVID-19 Ag to rapidly detect antigens of SARS-CoV-2, the virus which causes COVID-19. 

Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical.

The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers. This product is CLIA waived under FDA/EUA authorization.

As an intended point-of-care (POC) designated COVID test with a 10 minute processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.

  • Lateral flow assay
  • Rapid results in 10 minutes
  • Minimally invasive specimen collection (nasopharyngeal)
  • Intended at POC setting (i.e., in patient care settings) by medical professionals
  • Detect SARS-CoV-2 nucleocapsid protein antigen
  • Identify acute infection with high sensitivity and 100% specificity

The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers.


Important Information

  • This test has been authorized by FDA under an EUA for professional use.
  • This test has not been FDA cleared or approved.
  • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
  • This product is intended for professional use and not for home use.

This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.



Important Information:

Related Items

15 Minute Covid Rapid Test
COVID Rapid Antibody Test
$22.79
In stock and ships same or next day!
ImmunoPass COVID-19 Rapid Neutralizing Antibody Test
$600.00
Accepting preorders both online and by phone!
LifeSign Status™ COVID-19 Flu A&B
$749.00
In Stock and Ships Same or Next Day!

Recently Viewed Items